Evaluation of a ConvitVax/anti-PD-1 combined immunotherapy for breast cancer treatment
Breast cancer therapies using checkpoints alone have not been highly effective. Based on previous experiences using the ConvitVax, an autologous tumor
cells/bacillus Calmette-Guérin (BCG)/formalin-based vaccine, in breast cancer and the potential success of combined therapies…
Comentarios recientes